Compare MTLS & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTLS | TOI |
|---|---|---|
| Founded | 1990 | 2007 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.1M | 327.6M |
| IPO Year | 2014 | N/A |
| Metric | MTLS | TOI |
|---|---|---|
| Price | $5.08 | $3.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 108.7K | ★ 2.0M |
| Earning Date | 04-23-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.40 | $27.81 |
| Revenue Next Year | $7.22 | $25.94 |
| P/E Ratio | $61.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.93 | $0.86 |
| 52 Week High | $6.80 | $4.88 |
| Indicator | MTLS | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 69.80 |
| Support Level | $4.94 | $3.15 |
| Resistance Level | $5.39 | $4.09 |
| Average True Range (ATR) | 0.17 | 0.28 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 5.88 | 87.08 |
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.